TickerFactsScreenerDevelopers

enGene Therapeutics Inc. (ENGN) — EPS (Diluted)

Annual figures by fiscal year, from SEC filings.

2022: $44.302023: $151.222024: $1.462025: $2.29$2.29
2022EPS (Diluted) (USD/shares)2025
Fiscal YearEPS (Diluted)Change YoY
2025$2.29+56.8%
2024$1.46-99.0%
2023$151.22+241.4%
2022$44.30—